0000000000328677

AUTHOR

Bengt Winblad

showing 7 related works from this author

P2–182: Anxiety and depressive symptoms as predictors of progression from mild cognitive impairment to Alzheimer's disease

2006

Epidemiologybusiness.industryHealth PolicyDiseasePsychiatry and Mental healthCellular and Molecular NeuroscienceDevelopmental NeuroscienceMedicineAnxietyNeurology (clinical)Geriatrics and Gerontologymedicine.symptombusinessCognitive impairmentDepressive symptomsClinical psychologyAlzheimer's & Dementia
researchProduct

Occurrence of cognitive impairment and dementia in the community: a 9-year-long prospective study.

2008

Objective: To determine incidence rates of non-dementia cognitive impairment, to examine the impact of attrition due to death on the observed incidence estimates, and to compare the observed and corrected estimates of non-dementia cognitive impairment with dementia incidence rates. Methods: A total of 1,435 persons without dementia aged 75+ from the Kungsholmen Project were evaluated for occurrence of dementia over 9 years. A total of 1,070 cognitively unimpaired subjects were also followed using amnestic mild cognitive impairment (aMCI) and other cognitive impairment, no dementia (OCIND) definitions. To correct the observed incidence rates for attrition due to death, cognitive status for s…

GerontologyMalePediatricsmedicine.medical_specialtyAgingTime FactorsPopulationStatistics as TopicNeuropsychological TestsCohort Studiesmild cognitive impairmentPredictive Value of Testsmental disordersmedicineDementiaHumansProspective StudiesMortalityProspective cohort studyeducationAgedAged 80 and overSwedeneducation.field_of_studyMemory DisordersIncidence (epidemiology)IncidenceCognitive disorderAge FactorsCognitionmedicine.diseasePrognosisPredictive value of testsData Interpretation StatisticalepidemiologySettore MED/26 - NeurologiaDementiaFemaleNeurology (clinical)PsychologyCognition DisordersCohort studyNeurology
researchProduct

The symptom of low mood in the prodromal stage of mild cognitive impairment and dementia: a cohort study of a community dwelling elderly population.

2011

Objective: To investigate the symptom of low mood as a predictor of mild cognitive impairment (MCI) and its progression to dementia, taking into account: i) MCI severity, ii) time of assessment, iii) interaction with other factors. Methods: 764 cognitively healthy elderly living in the community, from the Kungsholmen Project. Participants were assessed by direct interview to detect low mood. Subjects were then followed for six years to identify those who developed MCI. People with incident MCI were followed for a further three years to assess progression to dementia. Results: People with low mood at baseline had a 2.7-fold (95% Confidence Interval [CI] 1.9-3.7) increased risk of developing …

MaleDatabases FactualApolipoprotein E4behavioral disciplines and activitiesProdromeCohort Studiesmild cognitive impairmentmental disordersmedicinedepression; epidemiology; mild cognitive impairment; dementiaDementiaHumansCognitive declineAgedSex CharacteristicsMood DisordersCognitive disorderProdromal StageCognitionmedicine.diseaseDiagnostic and Statistical Manual of Mental DisordersPsychiatry and Mental healthMoodData Interpretation StatisticaldepressionDisease ProgressionEducational StatusRegression AnalysisSurgeryepidemiologySettore MED/26 - NeurologiaDementiaFemaleNeurology (clinical)AmnesiaPsychologyCognition DisordersCohort studyClinical psychologyFollow-Up StudiesJournal of neurology, neurosurgery, and psychiatry
researchProduct

Heterogeneity in Risk Factors for Cognitive Impairment, No Dementia: Population-Based Longitudinal Study From the Kungsholmen Project

2006

OBJECTIVES: The objectives of this study were to investigate the relation of vascular, neuropsychiatric, social, and frailty-related factors with "Cognitive impairment, no dementia" (CIND) and to verify their effect independently of future progression to Alzheimer disease (AD). METHODS: Seven hundred eighteen subjects aged 75+ years who attended baseline, 3- and 6-year follow-up examinations of the Kungsholmen Project, a Swedish prospective cohort study, were studied. CIND was defined according to the performance on the Mini-Mental State Examination. Potential risk factors were collected at baseline and clustered according to four research hypotheses (frailty, vascular, neuropsychiatric, an…

MaleLongitudinal studyPsychosisPopulationAlzheimer DiseaseRisk FactorsActivities of Daily Livingmental disordersmedicineHumansDementiaeducationProspective cohort studyAgedProportional Hazards ModelsAged 80 and overSwedenPolypharmacyeducation.field_of_studyHip fractureHip FracturesMild cognitive impairment Alzheimer disease hip fracture polypharmacy psychosismedicine.diseasePsychiatry and Mental healthPsychotic DisordersDisease ProgressionPolypharmacyFemaleSettore MED/26 - NeurologiaGeriatrics and GerontologyAlzheimer's diseaseCognition DisordersPsychologyFollow-Up StudiesClinical psychologyThe American Journal of Geriatric Psychiatry
researchProduct

P4‐117: Low mood in late life and risk of amnestic versus other cognitive impairment with and without dementia: A longitudinal community‐based study

2008

EpidemiologyHealth Policymedicine.diseaseCommunity based studyPsychiatry and Mental healthCellular and Molecular NeuroscienceMoodDevelopmental NeurosciencemedicineDementiaNeurology (clinical)Geriatrics and GerontologyCognitive impairmentPsychologyClinical psychologyCognitive psychologyAlzheimer's & Dementia
researchProduct

Predictors of progression from mild cognitive impairment to Alzheimer disease.

2007

Objective: To determine the occurrence of neuropsychiatric symptomatology and the relation to future development of Alzheimer disease (AD) in persons with and without mild cognitive impairment (MCI). Method: We followed 185 persons with no cognitive impairment and 47 with MCI (amnestic and multidomain), ages 75 to 95, from the population-based Kungsholmen Project, Stockholm, Sweden, for 3 years. Three types of neuropsychiatric symptoms were assessed at baseline: mood-related depressive symptoms, motivation-related depressive symptoms, and anxiety-related symptomatology. AD at 3-year follow-up was diagnosed according to Diagnostic and Statistical Manual for Mental Disorders-III-R criteria. R…

Malemedicine.medical_specialtyMild Cognitive ImpairmentPopulationNeuropsychological Testsbehavioral disciplines and activitiesDysphoriaCohort StudiesAlzheimer DiseasePredictive Value of TestsRisk FactorsInternal medicinemental disordersmedicinePrevalenceHumanseducationSuicidal ideationAgedAged 80 and overeducation.field_of_studyDepressive DisorderMood Disordersmedicine.diseaseAlzheimer's disease EpidemiologyComorbidityAnxiety DisordersMoodMood disordersDisease ProgressionAnxietySettore MED/26 - NeurologiaFemaleNeurology (clinical)medicine.symptomAlzheimer's diseasePsychologyCognition DisordersClinical psychologyNeurology
researchProduct

The EADC-ADNI Harmonized Protocol for manual hippocampal segmentation on magnetic resonance : Evidence of validity

2014

BackgroundAn international Delphi panel has defined a harmonized protocol (HarP) for the manual segmentation of the hippocampus on MR. The aim of this study is to study the concurrent validity of the HarP toward local protocols, and its major sources of variance.MethodsFourteen tracers segmented 10 Alzheimer's Disease Neuroimaging Initiative (ADNI) cases scanned at 1.5 T and 3T following local protocols, qualified for segmentation based on the HarP through a standard web-platform and resegmented following the HarP. The five most accurate tracers followed the HarP to segment 15 ADNI cases acquired at three time points on both 1.5 T and 3T.ResultsThe agreement among tracers was relatively low…

MalePathologyDiagnostic criteriaEpidemiologyImage Processinggenetics [Alzheimer Disease]HippocampusFunctional LateralityImagingpathology [Alzheimer Disease]ddc:616.89methods [Magnetic Resonance Imaging]Computer-AssistedClinical trialsddc:150methods [Image Processing Computer-Assisted]ValidationImage Processing Computer-AssistedSegmentationHARPmedicine.diagnostic_testHealth PolicyOrgan SizeAlzheimer's diseaseMiddle Agedinstrumentation [Magnetic Resonance Imaging]Manual segmentationMagnetic Resonance ImagingPsychiatry and Mental healthMagnetic resonanceBiomedical ImagingManual segmentationFemalemethods [Neuroimaging]methods [Imaging Three-Dimensional]EADC-ADNI Working Group on The Harmonized Protocol for Manual Hippocampal Volumetry and for the Alzheimer's Disease Neuroimaging Initiativemedicine.medical_specialtyHippocampal volumetry; Magnetic resonance; Alzheimer's disease; Biomarkers; Diagnostic criteria; Enrichment; Clinical trials; Validation; Harmonized protocol; Standard operating procedures; Manual segmentationConcurrent validityClinical SciencesHarmonized protocolNeuroimagingArticleHippocampal volumetryCellular and Molecular NeuroscienceImaging Three-DimensionalDevelopmental NeuroscienceNeuroimagingClinical ResearchAlzheimer DiseasemedicineHumansddc:610AgedProtocol (science)ReproducibilityInternetbusiness.industryNeurosciencesReproducibility of ResultsMagnetic resonance imagingBrain DisordersStandard operating procedurespathology [Hippocampus]EnrichmentGeriatricsThree-DimensionalNeurology (clinical)Geriatrics and GerontologyAtrophyNuclear medicinebusinessBiomarkers
researchProduct